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Autophagy
● Autophagy is a catabolic process that degrades and recycles
damaged organelles and macromolecules within the cell
○ Autophagy is generally seen survival mechanism.
● Autophagy plays a key role in preventing diseases
○ It have also shown autophagy to be a tumor suppressive
mechanism

DNA Methylation
● DNA methylation is an epigenetic mechanism involving the transfer
of a methyl group onto the C5 position of the cytosine to form 5methylcytosine
○ DNA methylation regulates gene expression
● These epigenetic modifications, such as DNA methylation have
shown to be a part of carcinogenesis
● Promoter methylation may silence crucial genes that have been
shown to regulate autophagy in cancer.

Prostate Cancer
● Prostate cancer is the most frequent tumor found in men worldwide
● Previous studies have shown clear indications that stable
epigenomic changes occur in cells of prostate cancer.
● One of the most occurring events in prostate cancer is DNA
methylation.
● There may be a strong relationship in biological mechanisms and
pathways between promoter methylation in autophagy genes and
prostate cancer.

NAS Data
•

The Normative Aging Study (NAS) was established by the US
Department of Veteran Affairs (VA) in 1963

•

981 participants died and 470 were lost to follow up.

•

Participants were recalled for clinical examinations every 3–5 years

•

Starting in 1999, these included 7-ml blood samples for DNA
analysis.

•

This study was approved by the Institutional Review Boards of all
participating institutions, and all participants provided written
consent.

NAS Data (cont.)
•

Only cancer-free participants and participants with prostate cancer
were considered

•

36 (28.8%) had prostate cancer, while the remaining population had
digestive, skin, respiratory, and other cancers.

•

The remaining population of 402 participants was
further limited due to the nature of the all-male cohort.

•

The participants were then split into 3 groups based off the amount
of years before their diagnosis date: 0-4 years, 4-8 years, and 8+
years from their baseline date.

•

Information on cancer diagnosis was obtained from questionnaires
and confirmed via review of medical records.

Initial Analysis
•

Each group included the cancer-free participants for a comparison
analysis between the beta values that measure DNA methylation.

•

354 cancer-free participants, 0-4 years had 28 cancer participants,
4-8 years had 9 cancer participants, and 8+ years had 6 cancer
participants.

•

Each group was run through a robust linear regression and linear
regression model to get better insight into the significant CpG sites.

•

Only the CpGs that were significant between at least 2 of the groups
were considered and compared to understand the DNA methylation
changes.

Initial Analysis (cont.)
•

All models were adjusted for age, education, BMI, and cell
proportion.

•

Each group included the cancer-free participants for a comparison
analysis between the beta values that measure DNA methylation.

•

Each group was run through a robust linear regression and linear
regression model to get better insight into the significant CpG sites.

•

Only the CpGs that were significant between at least 2 of the groups
were considered and compared to understand the DNA methylation
changes.

Final Analysis
•

The robust linear regression model was later used to compare
between the groups.

•

Smoke years and alcohol consumption did not appreciably affect our
results, prompting their exclusion.

•

Participants missing any data for outcome was discluded

•

Figures were generated using R v3.5.1.

•

Statistical significance threshold was set to p = 0.01.

•

Sensitivity analyses and KEGG Pathway tests were run in order to
gain better insight into the significance of the results.

•

All models were adjusted for age, education, BMI, and cell
proportion.

Sensitivity and Genomic
Analysis
•

The purpose of the sensitivity analysis is to test the robustness of the
model.

•

A crude model was compared with the adjusted model to verify the
significance of the results.

•

Each showed a strong, positive correlation with r > 0.9.

•

Each CpG site showed a consistency between their respective
groups.

•

For Years 8+ and Years 0-4, the sensitivity analysis showed a
stronger correlation (r=0.959, r=0.969) compared to Years 4-8 (r =
0.942).

•

The genomic analysis failed to report anything significant to report
to further strengthen the results.

KEGG Pathway Analysis
•

Using the significant 22 CpG sites, 60 gene pathways were identified
by using the KEGG and statistical tests.

•

15 of the pathways were significant (p-value < 0.05).

•

The most significant pathways include necroptosis, calcium signaling
pathway, insulin secretion, circadian entrainment, gastric acid
secretion, and aldosterone synthesis and secretion (p < 0.01)

•

Mechanisms and regulation of necroptosis affects tumorigenesis

•

Calcium signaling has been showing signs of providing an effective
diagnosis and treatment of prostate cancer.

Conclusions
•

The robust linear model located 2,113 significant CpG sites.

•

The 22 significant and directionally consistent CpG sites were
considered further, and were limited down to 12 genes to consider
only the CpG sites that lied on the promoter region.

•

Previous studies have shown significant results for the 12 genes that
the CpG sites lie on.
•

HSP27, SQSTM1, TFEB, REL, VDAC1 remain consistent with my
findings

•

KRT74z, PRKCZ, SNORA84, TMEM49, SLC7A6, and BRSK2 are novel
biomarkers that need further research in order to verify their
autophagic effects in prostate cancer.

Conclusions (cont.)
•

The work in the field of autophagy and its relationship to cancer is
growing, as the complex associations and relationships between
autophagy and cancer are being explored.

•

This paper seeks to further clarify the relationship by verifying some
previously known mechanisms

•

This prospective study design allows pediatricians and
pharmaceutical companies to utilize this information and target these
biomarkers beforehand to develop a better prognosis and treatment
plan.

Future Research
•

Research into both calcium signaling and necroptosis molecular
mechanisms could potentially yield new biomarkers for researchers
to utilize.

•

The relationships between the functionality of autophagy and these
pathways to prostate cancer to create effective prognosis and
treatment methods for the future.
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